Skip to Content
Merck
CN
All Photos(1)

Key Documents

Safety Information

45182

Sigma-Aldrich

Enterotoxin B from Staphylococcus aureus

≥95% (GE)

Synonym(s):

SEB, Staphylococcal enterotoxin B

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
12352200

Assay

≥95% (GE)

mol wt

Mr ~29000

concentration

~25% protein

impurities

Sodium phosphate

solubility

H2O: 4 mg/mL, clear, colorless

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

高风险级别生物产品--毒素类产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Purification of staphylococcal enterotoxins.
J J Iandolo et al.
Methods in enzymology, 165, 43-52 (1988-01-01)
Susanna Lopez Kostka et al.
Journal of immunology (Baltimore, Md. : 1950), 182(5), 3039-3046 (2009-02-24)
Resistance to leishmaniasis in C57BL/6 mice depends on Th1/Tc1 cells. BALB/c mice preferentially develop Th2 immunity and succumb to infection. We now assessed the role of IL-17 in cutaneous leishmaniasis. During the course of Leishmania major infection, BALB/c CD4 cells
Alexandra Schuetz et al.
PloS one, 6(11), e27284-e27284 (2011-11-17)
The level of bacterial activity is only poorly defined during asymptomatic Mycobacterium tuberculosis (MTB) infection. The objective was to study the capacity of a new biomarker, the expression of the T cell maturation marker CD27 on MTB-specific CD4 T cells
Marla Lay et al.
Vaccine, 27(29), 3811-3820 (2009-05-02)
Safe and effective adjuvants for influenza vaccines that could increase both the levels of neutralizing antibody, including against drifted viral subtypes, and T-cell immunity would be a major advance in vaccine design. The JVRS-100 adjuvant, consisting of DOTIM/cholesterol cationic liposome-DNA
Xiao-Li Huang et al.
Clinical and vaccine immunology : CVI, 16(10), 1504-1516 (2009-08-21)
Human immunodeficiency virus type 1 (HIV-1)-specific T-cell reactivity has been related to protection from disease progression. Optimal T-cell reactivity to HIV-1 presumably requires antigen processing and presentation by professional antigen-presenting cells, particularly dendritic cells (DC). Here we examined whether multiple

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service